[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336216-105":59,"doc-detail-336216-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","mitochondrial-deoxyribonucleic-acid-copy-number-elevation-as-a-predictor-for-extended-survival-and-favorable-outcomes-in-high-grade-brain-tumor-patients-a-malaysian-study","Mitochondrial Deoxyribonucleic Acid Copy Number Elevation as a Predictor for Extended Survival and Favorable Outcomes in High-Grade Brain Tumor Patients - A Malaysian Study","","Background: Investigating mitochondrial DNA (mtDNA) alterations and their impact on brain tumor progression remains a significant focus in cancer research. The study examined contributions of mtDNA copy number changes and associations with survival, large mtDNA deletions, and TFAM mutations in brain tumor patients. Methods: Forty-one confirmed patients provided tumor tissue and blood for mtDNA quantification by qRT-PCR; long-range PCR evaluated large deletions and Sanger sequencing targeted exon 4 TFAM mutations. Results: mtDNA copy number increased in tumor tissue (80.5%) versus blood (P \u003C .001), and higher copy numbers correlated with longer overall survival and favorable outcomes, especially in high-grade cases. Conclusion: Increased mtDNA copy number supports improved survival and positive outcomes in high-grade brain tumor patients.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mitochondrial-deoxyribonucleic-acid-copy-number-elevation-as-a-predictor-for-extended-survival-and-favorable-outcomes-in-high-grade-brain-tumor-patients-a-malaysian-study/336216/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mitochondrial-deoxyribonucleic-acid-copy-number-elevation-as-a-predictor-for-extended-survival-and-favorable-outcomes-in-high-grade-brain-tumor-patients-a-malaysian-study/336216.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the primary aim of this study on brain tumor patients?","Question",{"text":112,"@type":113},"To explore how mtDNA copy number changes relate to patient survival, along with associations with large mtDNA deletions and TFAM mutations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were mtDNA copy numbers and deletions measured?",{"text":117,"@type":113},"Relative mtDNA copy number was quantified from tumor tissue and blood using qRT-PCR, long-range PCR assessed large-scale mtDNA deletions, and Sanger sequencing detected TFAM exon 4 mutations.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about mtDNA copy number in tumor tissue versus blood?",{"text":121,"@type":113},"mtDNA copy numbers were significantly higher in brain tumor tissues (80.5%) compared with matched blood samples (P \u003C .001).",{"name":123,"@type":110,"acceptedAnswer":124},"Did higher mtDNA copy number relate to clinical outcomes?",{"text":125,"@type":113},"Yes. Patients with higher mtDNA copy numbers showed longer overall survival and notably favorable outcomes, particularly in high-grade tumor cases.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},336216,1790654311,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":46,"preview_page_count":19,"preview_urls":148},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","J -      Original   \nNeurosciences  \nMitochondrial Deoxyribonucleic Acid Copy Number Elevation As a Predictor for Extended Survival and Favorable Outcomes in High-Grade Brain Tumor Patients: A Malaysian Study  \nSiti Muslihah Ab Radzak 1  , Siti Zulaikha Nashwa Mohd Khair 1  , Zamzuri Idris 1  , Wan Muhamad Amir Wan Ahmad2 , Azim Patar 1  , Abdul Aziz Mohamed Yusoff1   \nCite this article as: Ab Radzak SM, Mohd Khair SZN, Idris Z, Wan Ahmad WMA, Patar A,  \nMohamed Yusoff AA. Mitochondrial deoxyribonucleic acid copy number elevation as a predictor for extended survival and favorable outcomes in highgrade brain tumor patients: A Malaysian study. Eurasian J Med., 2024;56(1):7-14.  \n1 Department of Neurosciences, Universiti Sains Malaysia School of Medical Sciences, Kubang Kerian, Kelantan, Malaysia  \n2Department of Biostatistics, Universiti Sains Malaysia School of Dental Sciences, Kelantan, Malaysia, Kelantan, Malaysia  \nReceived: July 11, 2023  \nRevision requested: September 27, 2023  \nLast revision received: December 26, 2023  \nAccepted: December 26, 2023  \nCorresponding author: Abdul Aziz Mohamed Yusoff  \nE-mail: [azizmdy@yahoo.com](azizmdy@yahoo.com)  \nDOI 10.5152/eurasianjmed.2024.23172  \nContent of this journal is licensed under a Creative Commons Attribution 4.0 International License.  \nABSTRACT  \nBackground: Investigating the role of mitochondrial DNA (mtDNA) alterations and their impact on brain tumor progression remains a significant focus in cancer research. The research aimed to explore the specific contributions of mtDNA copy number changes and their correlations with patient survival, large mtDNA deletions, and TFAM mutations in brain tumor patients.  \nMethods: A total of 41 patients with confirmed brain tumors underwent DNA extraction from both tumor tissues and blood samples. The relative mtDNA copy number in comparison to the nuclear genome was quantified using quantitative real-time polymerase chain reaction (qRT-PCR). Long-range PCR assessed largescale mtDNA deletions, and Sanger sequencing was applied to detect exon 4 TFAM mutations.  \nResults: Analysis revealed significantly increased mtDNA copy numbers in brain tumor tissues (80.5%) compared to matched blood samples (P \u003C .001) . Median delta Ct (∆Ct) values were 7.35 in cancerous tissues and 11.81 in blood (P \u003C .001), with median relative mtDNA content of 0.0123 and 0.0006, respectively (P \u003C .001) . Patients with higher mtDNA copy numbers experienced longer overall survival periods (P = .045) and notably favorable outcomes, particularly in high-grade tumor cases (P = .016) . Furthermore, a singlenucleotide deletion was identified in exon 4 of TFAM in a patient with glioblastoma IV, while no large-scale mtDNA deletions were found in brain tumor patients.  \nConclusion: Our study strongly supports the role of increased mtDNA copy numbers as a reliable predictor for improved survival and positive outcomes in high-grade brain tumor patients.  \nKeywords: mtDNA copy number, brain tumors, survival predictor  \nIntroduction  \nBrain tumors rank among the deadliest human malignancies, causing substantial morbidity and mortality worldwide. The Global Cancer Observatory report estimated a global incidence of 308 102 new cases and 251 239 deaths from brain tumors in 2020.1  \nVarious cellular and molecular research methods highlight the molecular diversity of brain tumors, arising from the progressive gathering of genetic mutations and epigenetic alterations.2 Yet, comprehending the origins of both malignant and non-malignant brain tumors, especially regarding the genetic aspects of the mitochondrial genome, remains a challenging endeavor.  \nRenowned for their vital involvement in cellular energy production and contribution to reactive oxygen species (ROS), mitochondria play a crucial role in maintaining metabolic homeostasis and regulating the process of cell death. Possessing their own genome, mitochondria are believed to have evolved independently from nuclear DNA. The su","cbCaioNnjpGrfD6Y","https://ap.wps.com/l/cbCaioNnjpGrfD6Y","pdf",639160,"English","# Abstract\n# Introduction\n## Mitochondrial DNA and brain tumor lethality\n## Regulation of mtDNA copy number in physiology\n## TFAM and mitochondrial replication\n## mtDNA deletions and genomic instability\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What was the primary aim of this study on brain tumor patients?\",\"answer\":\"To explore how mtDNA copy number changes relate to patient survival, along with associations with large mtDNA deletions and TFAM mutations.\"},{\"question\":\"How were mtDNA copy numbers and deletions measured?\",\"answer\":\"Relative mtDNA copy number was quantified from tumor tissue and blood using qRT-PCR, long-range PCR assessed large-scale mtDNA deletions, and Sanger sequencing detected TFAM exon 4 mutations.\"},{\"question\":\"What did the study find about mtDNA copy number in tumor tissue versus blood?\",\"answer\":\"mtDNA copy numbers were significantly higher in brain tumor tissues (80.5%) compared with matched blood samples (P \\u003c .001).\"},{\"question\":\"Did higher mtDNA copy number relate to clinical outcomes?\",\"answer\":\"Yes. Patients with higher mtDNA copy numbers showed longer overall survival and notably favorable outcomes, particularly in high-grade tumor cases.\"}]","Mitochondrial Deoxyribonucleic Acid Copy Number Elevation as a Predictor for Extended Survival and Favorable Outcomes in High-Grade Brain Tumor Patients - A Malaysian Study | PDF",1790014153,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52f9cc24acf61f7df8c37325e2cb9959.webp",983,1280,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ececaca9af43816ec572d71653446e1d.webp",982,1278,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2e55716428d2635f7d592dd1f375e28.webp",981,1277,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6685979460838bcd77f1072ff907af1.webp",980,1276]